Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Titel:
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Auteur:
Turner, Nicholas Dent, Rebecca A. O’Shaughnessy, Joyce Kim, Sung-Bae Isakoff, Steven J. Barrios, Carlos Saji, Shigehira Bondarenko, Igor Nowecki, Zbigniew Lian, Qinshu Reilly, Sarah-Jayne Hinton, Heather Wongchenko, Matthew J. Kovic, Bruno Mani, Aruna Oliveira, Mafalda